International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Extracorporeal Membrane Oxygenation Machine Market Research Report 20222027: According to the latest report by IMARC Group, titled " ExtracorporealMembraneOxygenationMachineMarket:GlobalIndustryTrends,Share,Size,Grow th,OpportunityandForecast2022-2027
," the global extracorporeal membrane oxygenation machine market is expected to grow at a CAGR of 5.3% during 2022-2027.
Extracorporeal membrane oxygenation (ECMO) machine offers prolonged cardiac and respiratory support to patients during transplant surgeries. This miniaturized heart-lung equipment is used for draining the blood for oxygenating red blood cells (RBCs), removing carbon dioxide from the patient’s body and then pumping to circulate blood via an artificial lung back into the bloodstream of the individual. Apart from this, these devices can also be utilized in late-stage treatments or postcardiopulmonary bypass with heart or lung failure. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsa mple
The global market is majorly driven by the rising prevalence of respiratory and cardiovascular disorders. This is also supported by the growing geriatric population across the globe that is more prone to develop such medical conditions. Since ECMO is widely used for individuals suffering from respiratory or cardiac failure as a result of trauma, congenital disabilities or severe infections, this is providing a boost to the market growth. The market is further driven by the continual integration of ECMO devices with advanced technologies.
For instance, the advent of polymethyl pentene (PMP) fiber-based artificial membranes with enhanced biocompatibility and low resistance is gaining widespread prominence across healthcare settings. Some of the other factors contributing to the market growth include the launch of portable product variants, increasing healthcare expenditure capacity, and extensive research and development (R&D) activities conducted by key players to introduce ECMO devices with convenient oxygenation of the blood.
View Report TOC, Figures and Tables:
https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Component:
• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories
Breakup by Modality:
• Veno-Arterial
• Veno-Venous
• Arterio-Venous
Breakup by Patient Type:
• Neonates
• Pediatric
• Adult
Breakup by Application:
• Respiratory
• Cardiac
• ECPR
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape:
• Abbott Laboratories
• ALung Technologies Inc.
• Braile Biomedical
• Eurosets
• LivaNova PLC
• Medtronic
• MicroPort Scientific Corporation
• Nipro Medical Corporation
• Origen Biomedical Inc.
• Terumo Corporation
• Xenios AG.
1. Howhastheglobalextracorporealmembraneoxygenationmachinemarketperformedsofar andhowwillitperforminthecomingyears?
2. WhathasbeentheimpactofCOVID-19ontheglobalextracorporealmembraneoxygenation machinemarket?
3. Whatarethekeyregionalmarkets?
4. Whatisthebreakupofthemarketbasedonthecomponent?
5. Whatisthebreakupofthemarketbasedonthemodality?
6. Whatisthebreakupofthemarketbasedonthepatienttype?
7. Whatisthebreakupofthemarketbasedontheapplication?
8. Whatarethevariousstagesinthevaluechainoftheindustry?
9. Whatarethekeydrivingfactorsandchallengesintheindustry?
10. Whatisthestructureoftheglobalextracorporealmembraneoxygenationmachinemarketand whoarethekeyplayers?
11. Whatisthedegreeofcompetitionintheindustry?
Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
